Delaware District Court
Judge:Richard G Andrews
Case #: 1:25-cv-00349
Nature of Suit835 Property Rights - Patent – Abbreviated New Drug Application
Cause35:271 Patent Infringement
Case Filed:Mar 20, 2025
Last checked: Thursday Mar 20, 2025 5:09 PM EDT
Defendant
Lupin Limited
Defendant
Lupin Pharmaceuticals, Inc.
Plaintiff
Bayer AG
Represented By
Rodger Dallery Smith, II
Morris, Nichols, Arsht & Tunnell LLP
contact info
Derek James Fahnestock
Morris, Nichols, Arsht & Tunnell LLP
contact info
Plaintiff
Bayer Pharma AG
Represented By
Rodger Dallery Smith, II
Morris, Nichols, Arsht & Tunnell LLP
contact info
Derek James Fahnestock
Morris, Nichols, Arsht & Tunnell LLP
contact info
Plaintiff
Janssen Pharmaceuticals, Inc.
Represented By
Rodger Dallery Smith, II
Morris, Nichols, Arsht & Tunnell LLP
contact info
Derek James Fahnestock
Morris, Nichols, Arsht & Tunnell LLP
contact info


Docket last updated: 12 hours ago
Wednesday, March 26, 2025
utility Case Assigned/Reassigned Wed 03/26 12:33 PM
Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. (rjb)
Related: [-]
Friday, March 21, 2025
utility Remark Fri 03/21 8:56 AM
Remark: The MDL Panel has been notified. (cdd)
Related: [-]
Thursday, March 20, 2025
7 7 service Summons Issued Thu 03/20 4:21 PM
Summons Issued as to Lupin Limited on 3/20/2025; Lupin Pharmaceuticals, Inc. on 3/20/2025.(cdd)
Related: [-]
Att: 1 Summons Issued
6 6 misc Disclosure Statement - Rule 7.1 Thu 03/20 4:19 PM
Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Bayer AG for Bayer Pharma AG filed by Bayer AG, Bayer Pharma AG. (cdd)
Related: [-]
5 5 misc Disclosure Statement - Rule 7.1 Thu 03/20 4:18 PM
Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Johnson & Johnson for Janssen Pharmaceuticals, Inc. filed by Janssen Pharmaceuticals, Inc. (cdd)
Related: [-]
4 4 misc Patent/Trademark Report to Commissioner of Patents Thu 03/20 4:16 PM
Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,828,310 B2. (cdd)
Related: [-]
3 3 misc ANDA Form Thu 03/20 4:15 PM
Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 12/22/2023. Date of Expiration of Patent: (See Form). (cdd)
Related: [-]
2 2 misc Magistrate Consent Forms Thu 03/20 4:12 PM
Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (cdd)
Related: [-]
1 1 14 pgs cmp Complaint Thu 03/20 4:11 PM
COMPLAINT for ANDA/PATENT INFRINGEMENT filed with Jury Demand against Lupin Limited, Lupin Pharmaceuticals, Inc. ( Filing fee $ 405, receipt number ADEDC-4641999.) - filed by Bayer Pharma AG, Bayer AG, Janssen Pharmaceuticals, Inc.(cdd)
Related: [-]
Att: 1 Exhibit A - E,
Att: 2 Civil Cover Sheet